Apellis Pharmaceuticals, Inc.
Recent Filings
All 1,000 filings →| Form | Description | Date |
|---|---|---|
| SCHEDULE 13G/A | — | Mar 26, 2026 |
| 4 | 4 | Mar 13, 2026 |
| 4 | PRIMARY DOCUMENT | Mar 3, 2026 |
| 3 | PRIMARY DOCUMENT | Mar 3, 2026 |
| 8-K | 8-K | Mar 2, 2026 |
| S-8 | S-8 | Feb 24, 2026 |
| 10-K | 10-K | Feb 24, 2026 |
| SCHEDULE 13G | — | Feb 17, 2026 |
| 4 | PRIMARY DOCUMENT | Feb 13, 2026 |
| 144 | — | Feb 11, 2026 |
Insider Transactions
View all →| Insider | Title | Type | Shares | Owns After | Date |
|---|---|---|---|---|---|
| Watson David O. | General Counsel | Sale | 5,000 @ $24.49 | 103,730 | Dec 16, 2025 |
| Watson David O. | General Counsel | Sale | 5,000 @ $20.06 | 108,730 | Nov 17, 2025 |
| Sullivan Timothy Eugene | Chief Financial Officer | Sale | 10,000 @ $28.03 | 110,936 | Oct 21, 2025 |
| Watson David O. | General Counsel | Sale | 5,000 @ $25.22 | 113,730 | Oct 16, 2025 |
| Watson David O. | General Counsel | Sale | 5,000 @ $24.34 | 118,730 | Sep 16, 2025 |
| Chopas James George | VP/Chief Accounting Officer | Sale | 189 @ $24.19 | 53,468 | Sep 15, 2025 |
| Watson David O. | General Counsel | Sale | 20,000 @ $26.17 | 50,136 | Sep 10, 2025 |
| Sullivan Timothy Eugene | Chief Financial Officer | Sale | 10,000 @ $27.83 | 60,396 | Sep 8, 2025 |
| Chopas James George | VP/Chief Accounting Officer | Sale | 548 @ $28.08 | 53,657 | Sep 2, 2025 |
| Boucher Kelley | Chief People Officer | Award / Grant | 30,476 | 97,658 | Sep 2, 2025 |